Product NDC: | 50332-0127 |
Proprietary Name: | Relief-PE |
Non Proprietary Name: | ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
Active Ingredient(s): | 325; 2; 5 mg/1; mg/1; mg/1 & nbsp; ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50332-0127 |
Labeler Name: | NorMed |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part343 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20120416 |
Package NDC: | 50332-0127-7 |
Package Description: | 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0127-7) |
NDC Code | 50332-0127-7 |
Proprietary Name | Relief-PE |
Package Description | 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0127-7) |
Product NDC | 50332-0127 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20120416 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | NorMed |
Substance Name | ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 325; 2; 5 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |